farber_nixon_375

EmailShare

Dr. Sidney Farber (far left) was a White House guest of Pat (second from right) and President Richard Nixon after the president declared his “War on Cancer” and passed the National Cancer Act of 1971. When the president appointed 18 members to a National Cancer Advisory Board the following March, Dr. Farber was granted a four-year term.

Dr. Sidney Farber (far left) was a White House guest of Pat (second from right) and President Richard Nixon after the president declared his "War on Cancer” and passed the National Cancer Act of 1971. When the president appointed 18 members to a National Cancer Advisory Board the following March, Dr. Farber was granted a four-year term.

Dr. Sidney Farber (far left) was a White House guest of Pat (second from right) and President Richard Nixon after the president declared his “War on Cancer” and passed the National Cancer Act of 1971. When the president appointed 18 members to a National Cancer Advisory Board the following March, Dr. Farber was granted a four-year term.

Downloads: full (375x274) | thumbnail (100x100) | medium (300x219) | medium_large (375x274) | large (375x274)

Latest Tweets

Dana-Farber @danafarber
RT @PanMass: How to Talk to Your Family about Genetic Cancer Risk – @DanaFarber Insight https://t.co/gIL1yzrnES https://t.co/2fiaX2eV5G
Dana-Farber @danafarber
RT @ChrisWorsham: Terrific talk by Dr. James O’Connell on the origins of @BHCHP at the @DanaFarber pharmacists’ annual ethics lecture! http…

Make An Appointment

For adults: 877-442-3324

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.